Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wood Website

Lauren V. Wood, M.D.

Selected Publications

1)  Berzofsky JA, Wood LV, Terabe M.
Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
Expert Rev Vaccines. 12: 1115-8, 2013.
[Journal]
2)  Castiello L, Sabatino M, Zhao Y, Tumaini B, Ren J, Ping J, Wang E, Wood LV, Marincola FM, Puri RK, Stroncek DF.
Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.
Mol. Ther. 21: 476-84, 2013.
[Journal]
3)  Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV.
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
AIDS Care. 24: 1092-6, 2012.
[Journal]
4)  Arlen PM, Wood LV.
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era.
Expert Rev Vaccines. 11: 287-302, 2012.
[Journal]
5)  Berzofsky JA, Terabe M, Wood LV.
Strategies to use immune modulators in therapeutic vaccines against cancer.
Semin. Oncol. 39: 348-57, 2012.
[Journal]
6)  Wood LV.
Why I voted "no" to Truvada PrEP.
Ann. Intern. Med. 157: 519-20, 2012.
[Journal]
7)  Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
AIDS Patient Care STDS. 23: 593-601, 2009.
[Journal]
8)  Wiener LS, Battles HB, Wood LV.
A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior.
AIDS and behavior. 11: 471-8, 2007.
[Journal]
9)  Martin S, Elliott-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, Wood LV.
Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
Pediatr. Infect. Dis. J. 26: 61-7, 2007.
[Journal]
10)  Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, Roby G, Elliott-Desorbo DK.
The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity.
J Acquir Immune Defic Syndr. 2007.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/16/2014.